T 0305/07 (Trisulfides/PFIZER) of 20.05.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T030507.20110520
- Date of decision
- 20 May 2011
- Case number
- T 0305/07
- Petition for review of
- -
- Application number
- 99933442.8
- IPC class
- C07K 1/113
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method for the production of recombinant peptides with a low amount of trisulfides
- Applicant name
- Pfizer Health AB
- Opponent name
- Novo Nordisk A/S
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 122 half Sent
- Keywords
- Admissibility of experimental evidence (no); main request, auxiliary requests 1 and 2 - added subject-matter (yes);
auxiliary request 3 - added subject-matter, extension of scope (no); sufficiency of disclosure, novelty, inventive step (yes) - Catchword
- -
- Citing cases
- T 0005/14
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent based on the following documents:
Claims 1 to 5 of auxiliary request 3 filed with the statement of the grounds of appeal dated 11 May 2007;
Figures 1 and 2 as granted;
and
the description to be adapted thereto.